Ukrain: Non-Toxic Chemotherapy

Chelidonium/thiotepa injections

A review from the Eclectic Medicine International (EMI) staff at http://www.holisticcancersolutions.com/

Chelidonium/thiotepa injections, also known as UKRAIN, are as powerful an agent in the anti-cancer arsenal as the strongest chemotherapeutic substances, with one enormous difference: C/t is entirely non-toxic. Made of a common herb, Chelidonium, and of a synthetic drug, thiotepa, it was unveiled at the 13th International Congress of Chemotherapy in Vienna in August 1983. It is classified as a semisynthetic "reaction product".
What makes this substance so unique is that the combination of the herb and drug creates a mixture that is almost totally non-toxic to healthy cells. The formula has been patented both in Europe and in the USA.

C/t has shown 100% growth inhibition when tested against 100 different cancer cell lines. It is highly toxic to cancer cells through various biochemical activities.

The product had been tested with 70 terminal cancer patients in Austria, under the control of the Ministry of Science and Research of Austria. The drug was found "cytostatic or cytotoxic to human leukemias, non small and small cell lung cancers, colon cancers, central nervous system cancer, melanomas, ovarian cancer and renal cancer, among others."

The drug was administered either intramuscularly or intravenously either every day or every second to fifth day, for ten days to three months. Definite changes in blood parameters and/or metastases could be seen when remission of tumors and/or metastases occurred. The drug also normalized the metabolism, and especially the equilibrium of mineral salts and trace elements, even without changes in the diet of the patients.

Clinical trials are underway in many countries; however, in North America the medical establishment shows no interest in the product. There is no distribution available in the US, the drug must be ordered directly from Austria. In order to establish a major drug in American mainstream medicine, several hundred millions of dollars are needed. As a direct result of this policy, available mainstream cancer treatments are all variations on the same old therapeutic theme: highly toxic chemotherapy and radiation.

Dr. Robert Atkins MD, regards this compound as the single best anticancer agent he has tested to date. "Like chemotherapy, it kills cancer cells very well but, unlike chemotherapy, it spares normal cells, healthy tissue. If the medical community were willing to give it a try, it could replace chemotherapy in treating almost all cancers."

The efficacy of C/t has been proven in 46 universities and research institutes by over 150 scientists from 16 countries. Their results have been presented at more than 150 international medical congresses and published in more than 100 scientific articles.

Dr. Jesse Stoff MD, recommends the use of C/t for the treatment of cancer patients. "I use it for solid tumors such as breast, lung, and colon. It also supports liver function in important ways."

Dr. Brodie MD: " The main advantage of the drug is that it apparently selectively kills cancer cells, and not only does no harm to the body's defenses, it actually fortifies them."

Dr. Wolfgang Kostler MD: "C/t alters the oxygen consumption of cancer cells in an irreversible manner. Since the cancer cell stops "breathing" (called cell respiration) at this point, after 15 minutes of C/t treatment, they die."

C/t possesses a strong attraction (cytotoxic selectivity) for cancer cells, and when exposed to ultraviolet light, it glows. For these reasons, it can be used to determine whether a suspicious growth is malignant.

According to Dr. Atkins, C/t can do everything that conventional chemotherapy does but without any side effects, so it renders chemotherapy largely unnecessary.

Detailed documentation on hundreds of animal and human clinical trials is available from the manufacturer. Treatment protocol can be discussed with the research staff. The contact persons speak excellent English.

Name of treatment: Chaledonium/thiotepa injections (UKRAIN)

Manufacturer: UKRAINAN ANTI-CANCER INSTITUTE
Director, developer of the product: Dr. Wassyl J. Nowicky
Address: Margaretenstrasse 717, A-1040, Vienna, Austria
Tel: 43 1 586 12 23
E-mail: <nowicky@ukrin.com>

Doctors who use it in the United States (as published in the book, Definitive Guide to CANCER from Future Medicine Publishing):

Dr. Robert C. Atkins, MD (New York) Tel.: 212-758 2110 Fax: 212-754- 4284 (deceased)

Dr. Douglas Brodie, MD (Reno, Nevada) Tel.: 702-324-7071 Fax: 702-324-7639

Dr. Jesse Stoff, MD (Tucson, Arizona) Tel.: 520-290-4516 Fax: 520-290-6403

Cost of treatment: This medication is not inexpensive. The yearly cost of the injections can run to ten or fifteen thousand dollars or more.

TOP